Evaluation of soluble CD 25 as a clinical and autoimmune biomarker in primary Sjögren ’ s syndrome
Evaluation of soluble CD 25 as a clinical and autoimmune biomarker in primary Sjögren ’ s syndrome
复制标题
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
J. Chen;Y. Jin;C. Li;Y. Gan;J. Li;S. Chen;X. Sun;J. He;Z. Li
中科院分区：
文献类型：
--
作者：
J. Chen;Y. Jin;C. Li;Y. Gan;J. Li;S. Chen;X. Sun;J. He;Z. Li
临床与实验流变学2020北京大学人民医院流变免疫科，中国北京。Jiali Chen，MD Yuebo Jin，MD Chun Li，MD Yuzhou Gan，MD Jing Li，PhD Shi Chen，MD Xiaolin Sun，PhD Jing He，MD Zhanguo Li，MD，PhD请将信函发送至：Jing He，Department of Rheumatology and Immunology，Peking University People Hospital，11 Xizhimen South Street，Beijing 100044，China。电子邮箱：hejing1105@126.com和Zhanguo Li，电子邮箱：zgli99@aliyun.com接收日期：2020年5月4日;接受日期：2020年6月15日。临床实验风湿病2020; 38（增刊126）：S142-S149。©版权所有ClinCal和ExpErimEntal rhEpherology 2020。
Clinical and Experimental Rheumatology 2020 Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China. Jiali Chen, MD Yuebo Jin, MD Chun Li, MD Yuzhou Gan, MD Jing Li, PhD Shi Chen, MD Xiaolin Sun, PhD Jing He, MD Zhanguo Li, MD, PhD Please address correspondence to: Jing He, Department of Rheumatology and Immunology, Peking University People’s Hospital, 11 Xizhimen South Street, Beijing 100044, China. E-mail: hejing1105@126.com and Zhanguo Li, E-mail: zgli99@aliyun.com Received on May 4, 2020; accepted in revised form on June 15, 2020. Clin Exp Rheumatol 2020; 38 (Suppl. 126): S142-S149. © Copyright CliniCal and ExpErimEntal rhEumatology 2020.